CA
NZ
UK
AU
IND
US
COMPASS Pathways plc (NASDAQ:CMPS) shares declined in trading today even after the company reported positive 26-week results from its second Phase 3 trial of COMP360, a synthetic psilocybin treatment for treatment-resistant depression. COMPASS Pathways is a London-headquartered biotechnology company focused on accelerating patient access …
MeiraGTx Holdings plc (NASDAQ:MGTX) shares were little changed in trading today after the company announced a strategic investment agreement with Oberland Capital Management worth up to $400 million. MeiraGTx is a vertically integrated, clinical-stage genetic medicines company with offices in London and New York, …
Vivani Medical, Inc. (NASDAQ:VANI) shares moved modestly higher in trading today after the company announced a new agreement with Novo Nordisk to evaluate NPM-139, Vivani's ultra long-acting semaglutide implant designed for chronic weight management. Vivani is an Alameda, California-based biopharmaceutical company developing miniature, long-acting …
RxSight, Inc. (NASDAQ:RXST) shares moved lower in pre-market trading after the company issued preliminary second-quarter results that included a reduction to its sales guidance, even as it simultaneously announced a new collaboration agreement with Alcon. RxSight is an ophthalmic medical device company headquartered in …
NewGenIvf Group Limited (NASDAQ:NIVF) shares declined in pre-market trading even as the company announced plans to expand its advanced cytometry platform into the United Arab Emirates and wider Gulf Cooperation Council region. NewGenIvf is a Bangkok, Thailand-based holding company and assisted reproductive services provider …
AbbVie Inc. (NYSE:ABBV) shares moved modestly higher in pre-market trading, recovering from steeper session lows, after the company issued a preliminary second-quarter guidance update alongside a positive regulatory catalyst. AbbVie is a North Chicago, Illinois-based biopharmaceutical company spun off from Abbott Laboratories in 2013, …
Aligos Therapeutics, Inc. (NASDAQ:ALGS) shares moved higher in pre-market trading after the company confirmed that pevifoscorvir sodium, its lead hepatitis B candidate, received Breakthrough Therapy Designation from the Center for Drug Evaluation of China's National Medical Products Administration. Aligos is a clinical-stage biopharmaceutical company …
Context Therapeutics Inc. (NASDAQ:CNTX) shares moved higher in pre-market trading after the company confirmed its addition to the Russell 2000 and Russell 3000 indexes, a change that took effect following the annual reconstitution process. Context Therapeutics is a clinical-stage biopharmaceutical company headquartered in Philadelphia …
Genmab A/S (NASDAQ:GMAB) shares moved higher in pre-market trading after the European Commission granted marketing authorization for TEPKINLY in combination with lenalidomide and rituximab for adult patients with relapsed or refractory follicular lymphoma. Genmab is a Copenhagen, Denmark-based biotechnology company focused on developing antibody …
Tempus AI gained as its clinical AI data platform expanded genomic data library partnerships with oncology-focused pharmaceutical companies and health systems. The multimodal healthcare data moat and oncology genomics testing revenue provide near-term visibility while AI licensing builds.Key HighlightsOncology Genomics Testing Near-Term Revenue:Revenue from …
Please wait processing your request...